English
Home > Products > Letermovir intermediate

China Letermovir intermediate Factory

We have been proud from the higher consumer gratification and wide acceptance due to our persistent pursuit of high quality both on product or service and service for Letermovir intermediate,CAS NO 917389-26-5,917389-26-5,Letermovir advance intermediate,Letermovir N-3, With the eternal goal of "continuous quality improvement, customer satisfaction", we are sure that our product quality is stable and reliable and our products are best-selling at home and abroad.
Letermovir intermediate, We will supply much better products with diversified designs and professional services. At the same time, welcome OEM, ODM orders, invite friends at home and abroad together common development and achieve win-win, integrity innovation, and expand business opportunities! If you have any question or need more information please feel free to contact us. We are looking forward to receiving your enquiries soon.

Related Products

Hot Products

  • Piperacilloic Acid

    Piperacilloic Acid

    Product Name:Piperacilloic Acid
    Molecular Formula:C23H29N5O8S
    Molecular Weight:535.57
    CAS Registry Number:64817-22-7
  • 1(3H)-Isobenzofuranone, 5-phenoxy-

    1(3H)-Isobenzofuranone, 5-phenoxy-

    Product Name:1(3H)-Isobenzofuranone, 5-phenoxy-
    Molecular Formula:C14H10O3
    Molecular Weight:226.23
    CAS Registry Number:57830-14-5
  • Tubulysin A

    Tubulysin A

    Product Name:Tubulysin A
    Molecular Formula:C43H65N5O10S
    Molecular Weight;844.07
    CAS Registry Number;205304-86-5
  • 2,6-Dichlorofluorobenzene

    2,6-Dichlorofluorobenzene

    Product Name:2,6-Dichlorofluorobenzene
    Molecular Formula:C6H3Cl2F
    Molecular Weight:164.99
    CAS Registry Number:2268-05-5
  • 3-BROMOBENZENE-1,2-DIOL

    3-BROMOBENZENE-1,2-DIOL

    Product Name:3-BROMOBENZENE-1,2-DIOL
    Molecular Formula:C6H5BrO2
    Molecular Weight:189.01
    CAS Registry Number:14381-51-2
  • 5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER

    5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER

    Product Name:5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER
    Molecular Formula:C9H7BrN2O2
    Molecular Weight:255.07
    CAS Registry Number:898747-24-5
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept